|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.6 EUR | 0.00% |
|
-1.10% | -20.35% |
| Apr. 02 | Shedir Pharma, into 2023 with rising revenues; profit down single digits | AN |
| Mar. 29 | Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Shedir Pharma Group S.p.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 59.39 million compared to EUR 53.48 million a year ago. Revenue was EUR 60.22 million compared to EUR 54.59 million a year ago.
Net income was EUR 5.7 million compared to EUR 5.93 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.35% | 43.18M | |
| +26.47% | 661B | |
| +26.74% | 566B | |
| -6.33% | 352B | |
| +19.35% | 332B | |
| +4.23% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.04% | 145B |
SHEDIR PHARMA GROUP S.P.A. 
